SEHK:1681
SEHK:1681Pharmaceuticals

Consun Pharmaceutical Group (SEHK:1681) Valuation Check After Expanded HK$300 Million Share Buyback Plan

Consun Pharmaceutical Group expands buyback plan Consun Pharmaceutical Group (SEHK:1681) has expanded its existing share repurchase plan, adding HK$100 million to the programme to allow for up to HK$300 million in potential buybacks funded from existing cash resources. See our latest analysis for Consun Pharmaceutical Group. The increased buyback plan comes after a strong run in the shares, with a 15.54% 1 month share price return and a 20.23% 3 month share price return helping support a very...
SEHK:1310
SEHK:1310Telecom

HKBN (SEHK:1310) Deepens China Mobile Ties With Exclusive Venus Firewall Deal – What Really Changes?

In January 2026, HKBN Ltd. announced it had entered into a Distribution Framework Agreement with Venustech, a China Mobile Communications subsidiary, granting HKBN exclusive rights in Hong Kong and Macao for Venus Firewall products for the first year of a term running through 31 December 2028. The deal, classified as a continuing connected transaction under Hong Kong Listing Rules, effectively ties HKBN’s cybersecurity offering more closely to its controlling shareholder’s broader telecom...